The German health care system consists of the statutory and private health insurances, whereas the latter covers around 10% of the population. Anyhow, access and commercialization, especially of new and innovative therapies could firstly be introduced through the private system. What are the core differences to follow with such a strategy? What are the specifics of the private health insurances? And are there examples of such a market access pathway?
Dr. Stefan Walzer and Dr. Sebastian Biermann, representative of the Association of the private health insurance funds are discussing these questions and beyond.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: https://lnkd.in/dZtyKw8B (https://lnkd.in/dZtyKw8B)
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://lnkd.in/dDCTND2 (https://lnkd.in/dDCTND2)
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations